Genetically engineered models with alterations in cardiac membrane calcium-handling proteins.
about
Review of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studiesImpaired cardiac contractility response to hemodynamic stress in S100A1-deficient miceThree novel sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) 3 isoforms. Expression, regulation, and function of the membranes of the SERCA3 familyCardiac-specific overexpression of sarcolipin inhibits sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA2a) activity and impairs cardiac function in miceConditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathyA family of microRNAs encoded by myosin genes governs myosin expression and muscle performanceGene transfer: manipulating and monitoring function in cells and tissues.The GAR-3 muscarinic receptor cooperates with calcium signals to regulate muscle contraction in the Caenorhabditis elegans pharynxComplete heart block and sudden death in mice overexpressing calreticulin.Ca2+ clearance and contractility in vascular smooth muscle: evidence from gene-altered murine models.Modelling sarcoplasmic reticulum calcium ATPase and its regulation in cardiac myocytes.Elucidating the role of reversible protein phosphorylation in sepsis-induced myocardial dysfunctionThe role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acid metabolites in the development of cardiac hypertrophy induced by isoproterenol.Role of dual-site phospholamban phosphorylation in the stunned heart: insights from phospholamban site-specific mutants.The Role of Soluble Epoxide Hydrolase Enzyme on Daunorubicin-Mediated Cardiotoxicity.In vivo model with targeted cAMP biosensor reveals changes in receptor-microdomain communication in cardiac disease.Molecular properties of cardiac tail-anchored membrane protein SLMAP are consistent with structural role in arrangement of excitation-contraction coupling apparatus.
P2860
Q26746907-111AD21C-CF40-4125-AA66-BB0B34F8FBC0Q28209366-57AB0BDD-00CB-4675-9F91-CED4F0216E17Q28214899-C44AB45F-ECC1-41EA-9827-B01C8808EA9DQ28585152-D74CD712-AFDD-439D-BB7A-3312179E106BQ28593656-1E8C678B-4DB6-40E9-B8BA-0B82E88E1589Q29619547-6ED65E82-D463-401F-A302-FCBA8867594CQ34319684-497A6CAA-4A8C-45F4-8856-7099226AE97DQ34645174-4F744411-EEF9-41D5-BEC9-9BF1454553F6Q36166973-CA3E4B3C-0D8F-438A-B31A-F9EE1AF3520BQ36984701-46533337-7581-42C4-8D48-0B3C6CD8A0F1Q37469688-35CBE484-0293-4846-AD56-0F5FC8ACFCE6Q37522203-24BF4962-D705-415D-AE1B-AC79C8D4AF3EQ38714257-7F5D9229-D4AE-4CE4-883A-22AC0ADEEEE7Q44451696-912F79CD-18CE-4589-B13F-555111250D96Q47339443-B63480E5-E678-4367-AD3E-5E1DAC101E91Q48749621-0C2B7CA5-C723-46D2-B3E4-E9BFB7BA337AQ52062808-18C8385C-8C7B-48F7-9066-870A50F92207
P2860
Genetically engineered models with alterations in cardiac membrane calcium-handling proteins.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Genetically engineered models ...... ane calcium-handling proteins.
@ast
Genetically engineered models ...... ane calcium-handling proteins.
@en
type
label
Genetically engineered models ...... ane calcium-handling proteins.
@ast
Genetically engineered models ...... ane calcium-handling proteins.
@en
prefLabel
Genetically engineered models ...... ane calcium-handling proteins.
@ast
Genetically engineered models ...... ane calcium-handling proteins.
@en
P1476
Genetically engineered models ...... ane calcium-handling proteins.
@en
P2093
Kiriazis H
Kranias EG
P304
P356
10.1146/ANNUREV.PHYSIOL.62.1.321
P577
2000-01-01T00:00:00Z